ClinicalTrials.gg
Drug

Nebivolol clinical trials

Also written Bystolic.

studies test it
86
open now
5
in phase 3
20
first study started
2001

How each study uses Nebivolol is sorted by a rule, right about nine times in ten. Readers can ask us to read every study one by one.Ask us to read each study

Get an email when these change. Save the Nebivolol studies recruiting or about to start — once a week, free: studies that open, close, add sites or post results.

Get alerts for these studies
See an example email

Example · made-up studies

Breast cancer · Recruiting: 2 came in, 3 changed

What changed in your alerts, Oct 31 – Nov 6:

A study of drug A after surgery for early breast cancer

Came in · now Recruiting

Drug B with hormone therapy in advanced breast cancer

Changed

· Sites: 4 added, including Seoul and Busan

· Enrollment: 300 → 450 participants

Exercise during chemotherapy

Now Active, not recruiting

One email a week for all your alerts. Stop any time.

Approvals

The first approval found in each region, with its record

United States
17 Dec 2007 · BYSTOLIC · NDA 021742 (FDA, Drugs@FDA)
European Union
Not in EMA's list of EU-wide authorizations

From FDA's Drugs@FDA and Purple Book (through openFDA) and the European Medicines Agency, files of Sept 2026 and 27 Oct 2026. National approvals in Europe and other countries are not included. How this is worked out

How studies write it

Studies that test it under each name

Name

Nebivolol
70
Nebivolol 5 mg
5
Bystolic (TM)
3
Nebilet
2
Lobivon
2

Brand

Bystolic
28

In one entry with another drug

Given together, or one or the other

Nebivolol and Atenolol
2

Studies by the year they started

86 studies that test it; most in 2010 (12)

Studies that test Nebivolol, by start year
YearStudies
20014
20023
20031
20053
20062
20073
20087
200911
201012
20115
20127
20135
20141
20152
20161
20183
20192
20202
20214
20221
20231
20243
20252
20261

By phase

A phase 1/2 study counts in both.

Early Phase 1
2
Phase 1
3
Phase 2
9
Phase 3
20
Phase 4
42
No phase
13

What it is tested for

Each study’s main condition, where its own words name it, so a study counts once.

Who runs them

Industry 27 · Other 59

Forest Laboratories (11) · Mylan Bertek Pharmaceuticals (9) · Menarini International Operations Luxembourg SA (3) · Vanderbilt University (3) · Emory University (3) · Korea University Anam Hospital (2) · University of Florida (2) · University of California, San Diego (2)

Often tested with

Tested in the same studies.

Metoprolol (16) · Carvedilol (6) · Bisoprolol (5) · Atenolol (5) · Hydrochlorothiazide (4) · Lisinopril (4) · Propranolol (3) · Valsartan (3)

Related medicines

As reviewed, each with the page that says it.

Coming up

From the study records. Dates are the sponsors’ own estimates and often move.

Reaching primary completion within a year · 2, 1 in phase 3

Studies that test Nebivolol, phase 3 first.

Studies

Open first, then newest update. How each study uses Nebivolol is read from its arms, and is right about nine times in ten. Ask us to read each study. These are the studies that list it as an intervention; a search of ClinicalTrials.gov also finds studies that mention it only in a description, such as earlier treatment.

Testing it · 86

See all 86 studies that test Nebivolol →

As the comparator · 2 — what is tested is compared with Nebivolol

Codes

What other systems call Nebivolol · ClinicalTrials.gg INT006519

  • MeSH (NLM) D000068577NebivololConfirmed ClinicalTrials.gov, NLM, Wikidata
  • UNII (FDA) 030Y90569UNEBIVOLOLConfirmed FDA, NLM, Wikidata
  • RxNorm 31555Confirmed FDA, Wikidata
  • Wikidata Q27132971(S,R,R,R)-nebivololConfirmed FDA, NLM, Wikidata
  • Wikidata Q418130nebivololConfirmed FDA, NLM, Wikidata
  • NCI Thesaurus C66221NebivololOne source FDA
  • DrugBank DB04861One source Wikidata

Also registered as nebivolol hydrochloride (UNII JGS34J7L9I · RxNorm 236883).

“Confirmed” means two independent publishers link the code to this drug; “one source”, one does and its name agrees.